Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer’s disease
Year: 2020
Type: article
Abstract: A small molecule binds to a disordered protein in its monomeric form, preventing its aggregation linked to Alzheimer’s disease.
Source: Science Advances
Authors: Gabriella T. Heller, Francesco A. Aprile, Thomas C. T. Michaels, Ryan Limbocker, Michele Perni, Francesco Simone Ruggeri, Benedetta Mannini, Thomas Löhr, Massimiliano Bonomi, Carlo Camilloni, Alfonso De Simone, Isabella C. Felli, Roberta Pierattelli, Tuomas P. J. Knowles, Christopher M. Dobson, Michele Vendruscolo
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,500
Funders: National Science Foundation, Dell EMC, UK Research and Innovation, Alzheimer's Society, University of Cambridge, Agence Nationale de la Recherche, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Partnership for Advanced Computing in Europe AISBL, Cambridge Trust, Gates Cambridge Trust, Barcelona Supercomputing Center, Federal Aviation Administration, Horizon 2020 Framework Programme, Engineering and Physical Sciences Research Council, Science and Technology Facilities Council, Newnham College, University of Cambridge, Department of Biochemistry, University of Cambridge
Awards: G1861696716, Peta-5: A National Facility for Petascale Data Intensive Computation and Analytics, G3292921244, G358276009, G4664971511, Institut Convergences pour l’étude de l’Emergence des Pathologies au Travers des Individus et des populatiONs, G5420063140, Correlating biophysical properties of amyloid aggregates in vitro and in vivo by AFM-based infrared nanospectroscopy, Bringing Together Nanoscale and Bulk Approaches for the Biophysical Characterization of Protein Aggregation, G6661763476, G8292702431, G8322176006
OpenAlex ID: W3094788679
